Further, the significance of DNAJC10 expression varies among different cancers; for example, high DNAJC10 expression is associated with poor prognosis in patients with glioma,31 while DNAJC10 mRNA downregulation predicts weak OS and relapse‐free survival in patients with breast cancer.32 This evidence concerns the gene DNAJC10 and glioma.